Matteucci et al. (29) found that genes associated with cytokine signaling and expression were upregulated in patients with COVID-19, and the ex vivo treatment with Tα1-mitigated cytokine expression, and inhibited lymphocyte activation. This evidence concerns the gene TAAR1 and COVID-19.